Disclosures for "Evaluating the Safety and Efficacy of Different Intravenous Immunoglobulin 10 Percent Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients"
-
Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Therapeutics. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
-
Syed Rizvi has nothing to disclose.
-
Huub Kreuwel has received personal compensation for serving as an employee of Octapharma.